Next Generation Sequencing Market Size, Growth, Share & Trends Analysis
Report Code
BT 2697
Published in
Jan, 2026, By MarketsandMarkets™
Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Service, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2030
USD 29.53 BN
MARKET SIZE, 2030
CAGR 14.6%
(2025-2030)
700
REPORT PAGES
1000
MARKET TABLES
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The next-generation sequencing market, valued at US$13.95 billion in 2024, stood at US$14.94 billion in 2025 and is projected to advance at a resilient CAGR of 14.6% from 2025 to 2030, culminating in a forecasted valuation of US$29.53 billion by the end of the period. The expansion of the next-generation sequencing market is largely attributed to rapid improvements in sequencing technologies, rising demand for precision medicine, declining sequencing costs, and the increasing range of clinical applications.
KEY TAKEAWAYS
-
BY REGIONThe North American next-generation sequencing market accounted for a 41.8% revenue share in 2024.
-
BY OFFERINGBy offering, the next-generation sequencing market services segment is expected to register the highest CAGR of 18.2%.
-
BY TECHNOLOGYIn the next-generation sequencing market, by technology, the sequencing by synthesis segment will grow at a CAGR of 9.2%.
-
BY APPLICATIONIn the next-generation sequencing market, by application, the diagnostics segment is projected to grow at the fastest rate (13.9%) from 2025 to 2030.
-
PRODUCT, BY END USERIn the next-generation sequencing product market, by end user, the clinical & diagnostics laboratories segment dominated the market.
-
SERVICES, BY END USERIn the next-generation sequencing services market, by end user, the academic & research institutes segment dominated the market.
-
Competitive Landscape - Key PlayersCompanies PacBio, Illumina, Inc., Thermo Fisher Scientific, and Agilent Technologies were identified as some of the star players in the Next-Generation Sequencing (NGS) market, given their strong market share and offerings footprint.
-
Competitive Landscape - Startups/SMEsCompanies such as Singular Genomics Systems and Nucleus Biotech GmbH, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders
The next-generation sequencing (NGS) market continues to grow steadily. A key driver of this expansion is the clinical adoption of NGS across oncology, rare diseases, reproductive health, and infectious diseases. This trend is also accompanied by lower cost per genome and the launch of higher-throughput benchtop and clinical instruments. In addition, growth is further fueled by kitted library prep workflows, automation, and cloud/AI analytics that shorten sample-to-report times and improve data quality. Moreover, the emergence of national genomics initiatives, CDx/liquid biopsy (MRD) programs, long-read and single-cell/spatial multiomics, and collaborations among health systems, CROs, and platform providers are reshaping the competitive landscape. These changes are also deepening the recurring consumables and services base.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The next-generation sequencing landscape is changing. As the market shifts toward large-scale clinical use, there is a growing need for automated workflows and shorter turnaround times. The shifts in modality (long-read, single-cell/spatial, real-time nanopore) are broadening applications and, therefore, supporting growth in informatics, storage, and cloud/AI analytics. Stringent in vitro diagnostic regulations and more demanding payer evidence requirements are, therefore, setting higher standards for validation, LIMS traceability, and clinical utility demonstration.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Drivers
Impact
Level
Level
-
Rising clinical applications of sequencing
-
Declining sequencing cost
RESTRAINTS
Impact
Level
Level
-
Data analysis complexity
-
High initial capital investment
OPPORTUNITIES
Impact
Level
Level
-
Integration of AI and ML
-
Adoption of long-read sequencing technologies
CHALLENGES
Impact
Level
Level
-
Standardization Issues
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Advancements in sequencing platforms
Sequencing platforms have become faster, more accurate, and more user-friendly through various technological advances. With the ability to process large genomes and diverse samples in a single run, researchers can achieve quicker turnaround times, resulting in both cost and effort savings. Enhanced sequencing chemistries, such as more efficient fluorescent labeling and increased error correction, have contributed to higher data quality. NGS technology is now within reach of smaller laboratories and clinics, facilitated by the availability of compact automated systems and benchtop sequencers.
Restraint: High initial capital investment
High initial capital investment is a significant restraint on the NGS market, limiting adoption, especially in smaller labs, academic institutions, and emerging markets. The purchase price of advanced sequencing instruments ranges from hundreds of thousands to millions of dollars, creating a heavy financial burden. For instance, setting up an NGS facility requires investments in data storage, high-performance computing systems, and lab automation tools. Cost implications also include ongoing personnel training, equipment maintenance, and the continuous procurement of consumables.
Opportunity: Adoption of long-read sequencing technologies
The adoption of long-read sequencing technologies presents significant opportunities in the next-generation sequencing market by addressing critical challenges of short-read methods. Long-read platforms, such as those offered by Pacific Biosciences and Oxford Nanopore Technologies, enable sequencing of longer DNA or RNA fragments, producing more comprehensive and accurate genome assemblies. This is especially useful for analyzing complex genomic regions, such as structural variations, repetitive sequences, and phased haplotypes, which are difficult to resolve with short-read technologies.
Challenge: Standardization Issues
Standardization issues pose a significant challenge in the next-generation sequencing market, undermining the reproducibility, reliability, and scalability of sequencing workflows. The absence of uniform protocols for sample preparation, library construction, and data analysis leads to variability in results across laboratories and platforms. This inconsistency can hinder dataset comparability and complicate multi-center studies or collaborative research projects. In clinical applications, the lack of standardized guidelines for test validation and regulatory compliance, particularly across regions, creates hurdles to the widespread adoption of NGS-based diagnostics.
NEXT GENERATION SEQUENCING MARKET SIZE, GROWTH, SHARE & TRENDS ANALYSIS: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Nationwide clinical whole genome sequencing (WGS) for rare disease & cancer using Illumina NovaSeq/HiSeq + DRAGEN pipelines. | Higher diagnostic yield | Shorter diagnostic odyssey | Scalable national service. |
 |
Targeted oncology/constitutional testing on Thermo Fisher Ion Torrent (Oncomine/AmpliSeq) panels within a CLIA lab. | Rapid panel TAT | Cost-effective targeted profiling with established QC. |
 |
Clinical WGS service on Illumina platforms integrated with lab LIMS and confirmatory orthogonal tests. | Broader diagnostic yield | Standardized clinical reporting. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The ecosystem perspective of the next-generation sequencing market reveals the interconnected stakeholders, resources, and interactions that support the industry. The core consists of organizations directly involved in the development, manufacturing, distribution, and use of sequencing technologies. These include technology innovators, consumables suppliers, service providers, and end users such as research institutes, clinical laboratories, and biotechnology companies. Moreover, regulators and standards bodies, which influence market direction, innovation priorities, and the responsible use of genomic data, are also key players.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Next-Generation Sequencing (NGS) Market, By Offering
In 2024, the products segment held the largest share of the market, driven by repeat purchases and steady workflow demand. Most sequencing labs consistently spend on library prep kits, sequencing reagents, flow cells/chips, sample prep consumables, and QC reagents, making products a critical part of NGS operations.
Next-Generation Sequencing Products Market, By Type
In 2024, consumables dominated the NGS products market because they are used in every run and repurchased continuously. This includes library preparation kits, sequencing reagents, flow cells/chips, target enrichment panels, buffers, and other consumables. Moreover, sequencing volumes are increasing in clinical testing (mainly for oncology, NIPT, rare disease, and infectious disease) and in large research programs (population genomics, longitudinal studies), driving higher reagent consumption.
Next-Generation Sequencing Platforms Market, By Technology
Sequencing by synthesis (SBS) was the dominant technology in the NGS platforms market in 2024, largely due to its excellent combination of high accuracy, high throughput, and low cost. SBS instruments are widely used in large-scale genomics centers as well as in routine laboratories; thus, they have become a preferred choice for whole-genome, whole-exome, targeted panels, transcriptomics, and other high-volume applications.
Next-Generation Sequencing Products Market, By Workflow
In 2024, the sequencing step dominated the NGS products market by workflow because it drives the highest recurring spend per sample. Once libraries are prepared, every run requires sequencing kits and reagents, flow cells or sequencing chips, buffers, and run-specific plastics. These costs scale directly with sample volume and depth of coverage.
Next-Generation Sequencing Services Market, By Type
Sequencing services led the NGS services market by type in 2024, largely because the majority of customers outsource the most resource-intensive step. Sequencing requires costly equipment, qualified personnel, stringent quality control, and a continuous supply of reagents, all of which are difficult for small laboratories to sustain internally. Moreover, service providers are a favored choice for projects with fluctuating sample volumes, as they offer short turnaround times, uniform workflows, and scalable capacity.
Next-Generation Sequencing (NGS) Market, By Application
In 2024, diagnostics held the largest share of the NGS services market by application, as clinical demand shifted from research to routine patient testing. Oncology testing was a key focus. Many labs outsourced comprehensive genomic profiling and MRD-focused sequencing to access validated workflows and consistent reporting.
REGION
Asia Pacific to be fastest-growing region in global next-generation sequencing market during forecast period
The Asia Pacific next-generation sequencing market is expected to grow at the fastest rate during the forecast period. The Asia Pacific region, with its diverse population and a range of genetic backgrounds and healthcare issues, would benefit from NGS. NGS enables the comprehension of genetic diversity, the identification of disease-causing mutations, and the creation of regionally specific healthcare solutions. Ongoing development will lead to genomic advancements and better healthcare delivery, and the Asia Pacific region is expected to witness a sharp increase in the use of these technologies in research and clinical settings.
NEXT GENERATION SEQUENCING MARKET SIZE, GROWTH, SHARE & TRENDS ANALYSIS: COMPANY EVALUATION MATRIX
In the NGS market matrix, Illumina (Star) leads with a large installed base of clinical and research sequencers (for example, high-throughput and benchtop platforms), an anchored consumables model, and integrated secondary analysis. This breadth across oncology, rare-disease, reproductive health, and surveillance applications, combined with global service and regulatory-ready workflows, positions Illumina as the reference vendor for many laboratories. BD (Emerging Leader) is strengthening its position through single-cell and sample-to-sequencing workflows, bridging cellular phenotyping with NGS readouts. As multi-omics and cell-resolved applications expand, BD's portfolio depth in cell preparation and single-cell library generation supports progression toward the leaders' quadrant.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Illumina, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- Agilent Technologies, Inc. (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- QIAGEN (Germany)
- Danaher Corporation (US)
- Revvity (US)
- Eurofins Scientific (Luxembourg)
- PacBio (US)
- Oxford Nanopore Technologies plc. (UK)
- Takara Bio Inc. (Japan)
- BGI Group (China)
- Merck KGaA (Germany)
- BD (US)
- 10X Genomics (US)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2024 (Value) | USD 13.95 Billion |
| Market Forecast in 2030 (Value) | USD 29.53 Billion |
| Growth Rate | CAGR of 14.6% from 2025-2030 |
| Years Considered | 2023-2030 |
| Base Year | 2024 |
| Forecast Period | 2024-2030 |
| Units Considered | Value (USD Billion) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East, Africa |
WHAT IS IN IT FOR YOU: NEXT GENERATION SEQUENCING MARKET SIZE, GROWTH, SHARE & TRENDS ANALYSIS REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| US Next-Generation Sequencing (NGS) Market Assessment | Country-level sizing and forecast by technology, application, and end user, including pricing and adoption trends | Enables focused market strategy and investment planning in the US NGS space |
| Competitive Benchmarking of Leading Companies | Comparative profiling of key NGS players covering platform offerings, technological advancements, pricing, and strategic partnerships | Provides insights into competitor strengths and market positioning for strategic decision-making |
RECENT DEVELOPMENTS
- September 2025 : Illumina announced the launch of Illumina Protein Prep, an assay designed for next-generation sequencing (NGS)-based proteomics research. The product enables integration of proteomics into large-scale genomics studies across cancer, cardiometabolic, and immunologic research.
- July 2025 : QIAGEN launched its new QIAseq xHYB Long Read Panels, a set of target enrichment tools designed to support long-read sequencing of complex genomic regions. The panels are optimized for compatibility with native long-read platforms, such as those from PacBio, and are intended to improve detection of a broader range of genomic variations.
- February 2025 : Roche announced the launch of its sequencing by expansion (SBX) technology, a proprietary next-generation sequencing method. The SBX chemistry, paired with a sensor module, is designed to enable rapid, scalable sequencing for various applications.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TITLE
PAGE NO
1
INTRODUCTION
56
2
RESEARCH METHODOLOGY
61
3
EXECUTIVE SUMMARY
73
4
PREMIUM INSIGHTS
78
5
MARKET OVERVIEW
Explore how declining sequencing costs and AI integration drive precision medicine's growth.
81
5.1
INTRODUCTION
5.2
MARKET DYNAMICS
5.2.1
DRIVERS
5.2.1.1
ADVANCEMENTS IN SEQUENCING PLATFORMS
5.2.1.1.1
REVIO
5.2.1.1.2
PROMETHION 2 SOLO
5.2.1.1.3
ION TORRENT GENEXUS DX
5.2.1.2
RISING CLINICAL APPLICATIONS OF SEQUENCING
5.2.1.3
GROWING DEMAND FOR PRECISION MEDICINE
5.2.1.4
DECLINING COSTS OF SEQUENCING
5.2.2
RESTRAINTS
5.2.2.1
DATA ANALYSIS COMPLEXITY
5.2.2.2
HIGH CAPITAL INVESTMENT AND EXPENSES
5.2.3
OPPORTUNITIES
5.2.3.1
INTEGRATION OF AI AND ML
5.2.3.2
ADOPTION OF LONG-READ SEQUENCING TECHNOLOGIES
5.2.3.3
EMPHASIS ON MULTIOMICS INTEGRATION
5.2.4
CHALLENGES
5.2.4.1
STANDARDIZATION ISSUES
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4
REGULATORY LANDSCAPE
5.4.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.4.2
REGULATORY FRAMEWORK
5.5
VALUE CHAIN ANALYSIS
5.6
TECHNOLOGY ANALYSIS
5.6.1
KEY TECHNOLOGIES
5.6.1.1
SEQUENCING BY SYNTHESIS
5.6.1.2
SINGLE-MOLECULE REAL-TIME SEQUENCING
5.6.1.3
NANOPORE SEQUENCING
5.6.1.4
ION SEMICONDUCTOR SEQUENCING
5.6.2
COMPLEMENTARY TECHNOLOGIES
5.6.2.1
AUTOMATED SAMPLE PREPARATION SYSTEMS
5.6.2.2
BIOINFORMATICS AND DATA ANALYSIS PLATFORMS
5.6.2.3
CRISPR-BASED TARGETED SEQUENCING
5.6.2.4
MULTIPLEX PCR
5.6.3
ADJACENT TECHNOLOGIES
5.6.3.1
SINGLE-CELL SEQUENCING TECHNOLOGY
5.6.3.2
MULTI-OMICS INTEGRATION
5.6.3.3
SPATIAL GENOMICS AND TRANSCRIPTOMICS
5.6.3.4
GENE EDITING TECHNOLOGIES
5.7
PRICING ANALYSIS
5.7.1
AVERAGE SELLING PRICE TREND, BY KEY PLAYER
5.7.1.1
AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2018–2023
5.7.1.2
AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2022–2024
5.7.1.3
AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2024
5.7.2
AVERAGE SELLING PRICE, BY REGION
5.8
PATENT ANALYSIS
5.9
SUPPLY CHAIN ANALYSIS
5.10
ECOSYSTEM ANALYSIS
5.11
KEY CONFERENCES AND EVENTS, 2024–2025
5.12
PORTER’S FIVE FORCES ANALYSIS
5.12.1
INTENSITY OF COMPETITIVE RIVALRY
5.12.2
BARGAINING POWER OF SUPPLIERS
5.12.3
BARGAINING POWER OF BUYERS
5.12.4
THREAT OF SUBSTITUTES
5.12.5
THREAT OF NEW ENTRANTS
5.13
KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2
KEY BUYING CRITERIA, BY END USER
5.14
INVESTMENT AND FUNDING SCENARIO
5.15
CASE STUDY ANALYSIS
5.15.1
CASE STUDY 1: IDENTIFYING TANDEM REPEAT LINKED TO ALS USING SMRT SEQUENCING
5.15.2
CASE STUDY 2: LONG-READ WHOLE-GENOME SEQUENCING AT CHILDREN’S MERCY KANSAS CITY
5.15.3
CASE STUDY 3: SNP ARRAY IDENTIFIED INHERITED GENETIC DISORDER CONTRIBUTING TO IVF FAILURES
5.16
TRADE ANALYSIS
5.16.1
IMPORT DATA
5.16.2
EXPORT DATA
5.17
IMPACT OF AI ON NEXT-GENERATION SEQUENCING MARKET
6
NEXT-GENERATION SEQUENCING MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 15 Data Tables
122
6.1
INTRODUCTION
6.2
PRODUCTS
6.2.1
WIDE DEMAND FOR CONSUMABLES AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET
6.3
SERVICES
6.3.1
SHIFT TOWARD SERVICE-BASED MODELS TO DRIVE MARKET
7
NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million and Units | 93 Data Tables
131
7.1
INTRODUCTION
7.2
CONSUMABLES
7.2.1
LIBRARY PREPARATION & AND REAGENTS
7.2.1.1
STRONG DEMAND AND GROWING APPLICATIONS TO ENSURE MARKET GROWTH
7.2.2
SEQUENCING KITS & REAGENTS
7.2.2.1
TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH
7.2.3
OTHER CONSUMABLES
7.3
PLATFORMS
7.3.1
SEQUENCING PLATFORMS
7.3.1.1
ILLUMINA
7.3.1.1.1
NOVASEQ
7.3.1.1.2
NEXTSEQ
7.3.1.1.3
MISEQ
7.3.1.1.4
MINISEQ
7.3.1.1.5
ISEQ 100
7.3.1.2
THERMO FISHER SCIENTIFIC
7.3.1.3
PACBIO
7.3.1.4
OXFORD NANOPORE TECHNOLOGIES
7.3.1.5
OTHER SEQUENCING PLATFORMS
7.3.2
LIBRARY PREPARATION PLATFORMS
7.3.2.1
RISING DEMAND FOR SEQUENCING IN CLINICAL APPLICATIONS TO DRIVE MARKET
7.4
BIOINFORMATICS TOOLS
7.4.1
DATA ANALYSIS SOFTWARE & WORKBENCHES
7.4.1.1
DEMAND FOR GENOME ANALYSIS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH
7.4.2
DATA VISUALIZATION TOOLS
7.4.2.1
RISING DEMAND FOR SEQUENCING-BASED RESEARCH TO SUPPORT MARKET GROWTH
7.4.3
OTHER BIOINFORMATICS TOOLS
8
NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 37 Data Tables
180
8.1
INTRODUCTION
8.2
SEQUENCING BY SYNTHESIS
8.2.1
HIGH, RAPID PRODUCTION OF BASE PAIRS TO SUPPORT ADOPTION
8.3
ION SEMICONDUCTOR SEQUENCING
8.3.1
SIMPLER WORKFLOW AND COST-EFFECTIVENESS TO SUPPORT MARKET GROWTH
8.4
SMRT SEQUENCING
8.4.1
RAPID RESULTS AND LOWER SEQUENCING COSTS TO DRIVE MARKET
8.5
NANOPORE SEQUENCING
8.5.1
DIRECT RNA SEQUENCING CAPABILITIES TO PROPEL DEMAND
8.6
OTHER SEQUENCING TECHNOLOGIES
9
NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY WORKFLOW
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 22 Data Tables
201
9.1
INTRODUCTION
9.2
SEQUENCING
9.2.1
DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING TO DRIVE MARKET
9.3
PRESEQUENCING
9.3.1
DEVELOPMENT OF ADVANCED LIBRARY PREPARATION SOLUTIONS TO BOOST MARKET GROWTH
9.4
DATA ANALYSIS
9.4.1
DEVELOPMENT OF ADVANCED BIOINFORMATICS SOLUTIONS TO DRIVE MARKET
10
NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 29 Data Tables
214
10.1
INTRODUCTION
10.2
ACADEMIC & RESEARCH INSTITUTES
10.2.1
RISING RESEARCH INTENSITY FOR GENOME RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH
10.3
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3.1
RISING DEMAND FOR COMPREHENSIVE SEQUENCING DATA IN GENETIC RESEARCH TO DRIVE MARKET
10.4
CLINICAL & DIAGNOSTIC LABORATORIES
10.4.1
INCREASED APPLICATIONS IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE MARKET GROWTH
10.5
OTHER END USERS
11
NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 123 Data Tables
230
11.1
INTRODUCTION
11.2
SEQUENCING SERVICES
11.2.1
EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS
11.2.1.1
DEVELOPMENT OF TECHNOLOGICALLY ADVANCED NGS PRODUCTS AND SERVICES TO PROPEL GROWTH
11.2.2
RNA SEQUENCING
11.2.2.1
TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH
11.2.3
DE NOVO SEQUENCING
11.2.3.1
RISING AWARENESS OF DE NOVO SEQUENCING TO DRIVE MARKET
11.2.4
CHIP SEQUENCING
11.2.4.1
INCREASED DEMAND FOR CHIP SEQUENCING TO PROPEL GROWTH
11.2.5
WHOLE-GENOME SEQUENCING
11.2.5.1
REDUCED COST OF WGS TO SUPPORT MARKET GROWTH
11.2.6
METHYL SEQUENCING
11.2.6.1
INCREASED DEMAND FOR METHYL SEQUENCING IN CANCER RESEARCH TO SUPPORT MARKET GROWTH
11.2.7
OTHER SEQUENCING SERVICES
11.3
PRESEQUENCING SERVICES
11.3.1
LIBRARY PREPARATION & TARGET ENRICHMENT
11.3.1.1
DEVELOPMENT OF ADVANCED LIBRARY PREPARATION SOLUTIONS TO DRIVE MARKET
11.3.2
SAMPLE PREPARATION
11.3.2.1
DEVELOPMENT OF AUTOMATED SAMPLE PREPARATION SOLUTIONS TO BOOST GROWTH
11.3.3
QUALITY CONTROL
11.3.3.1
IMPORTANCE OF QUALITY CONTROL IN NGS WORKFLOW TO BOOST GROWTH
11.4
BIOINFORMATICS & DATA ANALYSIS SERVICES
11.4.1
DATA ANALYSIS
11.4.1.1
INCREASING DEMAND FOR GENOME ANALYSIS FOR CLINICAL DIAGNOSIS TO DRIVE MARKET
11.4.2
DATA VISUALIZATION & INTERPRETATION
11.4.2.1
RISING DEMAND FOR SEQUENCING-BASED RESEARCH TO SUPPORT MARKET GROWTH
11.4.3
DATA STORAGE & MANAGEMENT
11.4.3.1
DEMAND FOR EFFECTIVE DATA MANAGEMENT TO PROPEL MARKET GROWTH
11.5
NGS PLATFORM SERVICES
11.5.1
NEED FOR COMPLIANCE AND MINIMIZING PLATFORM DOWNTIME TO DRIVE ADOPTION
12
NEXT-GENERATION SEQUENCING SERVICES MARKET, BY WORKFLOW
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 22 Data Tables
291
12.1
INTRODUCTION
12.2
SEQUENCING
12.2.1
RISING DEMAND FOR SEQUENCING SERVICES AND APPLICATIONS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH
12.3
PRESEQUENCING SERVICES
12.3.1
CUSTOM DEVELOPMENT OF SAMPLES FOR SEQUENCING TO BOOST MARKET GROWTH
12.4
DATA ANALYSIS SERVICES
12.4.1
RISING DEMAND FOR ADVANCED RESEARCH TO DRIVE MARKET
13
NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 29 Data Tables
303
13.1
INTRODUCTION
13.2
ACADEMIC & RESEARCH INSTITUTES
13.2.1
RISING RESEARCH INTENSITY TO SUPPORT MARKET GROWTH
13.3
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
13.3.1
RISING DEMAND FOR COMPREHENSIVE GENETIC DATA TO DRIVE GROWTH
13.4
HOSPITALS & CLINICAL LABORATORIES
13.4.1
INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE MARKET GROWTH
13.5
OTHER END USERS
14
NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 74 Data Tables
319
14.1
INTRODUCTION
14.2
DIAGNOSTICS
14.2.1
CANCER DIAGNOSTICS
14.2.1.1
RISING DEMAND FOR TARGETED THERAPIES TO DRIVE MARKET
14.2.2
INFECTIOUS DISEASE DIAGNOSTICS
14.2.2.1
RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL DIAGNOSTICS TO PROPEL ADOPTION
14.2.3
REPRODUCTIVE HEALTH DIAGNOSTICS
14.2.3.1
FOCUS ON GENETIC DISEASE DIAGNOSTICS TO DRIVE GROWTH
14.2.4
OTHER DIAGNOSTIC APPLICATIONS
14.3
DRUG DISCOVERY & DEVELOPMENT
14.3.1
PHARMACOGENOMICS
14.3.1.1
RISING USE OF NGS FOR UNDERSTANDING GENOMIC VARIANTS IN HUMANS TO DRIVE GROWTH
14.3.2
OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS
14.4
AGRICULTURE & ANIMAL RESEARCH
14.4.1
EMPHASIS ON IMPROVING CROP PRODUCTIVITY TO DRIVE ADOPTION OF NGS
14.5
OTHER APPLICATIONS
15
NEXT-GENERATION SEQUENCING MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 17 Countries | 506 Data Tables.
357
15.1
INTRODUCTION
15.2
NORTH AMERICA
15.2.1
NORTH AMERICA: MACROECONOMIC OUTLOOK
15.2.2
US
15.2.2.1
US EXPECTED TO DOMINATE MARKET IN NORTH AMERICA
15.2.3
CANADA
15.2.3.1
INCREASING GOVERNMENT INITIATIVES IN SEQUENCING RESEARCH TO BOOST MARKET GROWTH
15.3
EUROPE
15.3.1
EUROPE: MACROECONOMIC OUTLOOK
15.3.2
GERMANY
15.3.2.1
GERMANY TO DOMINATE EUROPEAN NGS MARKET
15.3.3
UK
15.3.3.1
STRATEGIC INITIATIVES AND FUNDING FOR GENOMICS RESEARCH TO SUPPORT MARKET GROWTH
15.3.4
FRANCE
15.3.4.1
INCREASING GOVERNMENT INVESTMENT IN GENOMICS RESEARCH TO DRIVE GROWTH
15.3.5
ITALY
15.3.5.1
FAVORABLE FUNDING SCENARIO TO DRIVE ADOPTION OF ADVANCED SEQUENCING TECHNOLOGY
15.3.6
SPAIN
15.3.6.1
GROWING FOCUS ON ADVANCEMENTS IN PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH
15.3.7
NETHERLANDS
15.3.7.1
WELL-ESTABLISHED RESEARCH INFRASTRUCTURE TO SUSTAIN DEMAND FOR NGS
15.3.8
REST OF EUROPE
15.4
ASIA PACIFIC
15.4.1
ASIA PACIFIC: MACROECONOMIC OUTLOOK
15.4.2
CHINA
15.4.2.1
CHINA TO DOMINATE ASIA PACIFIC MARKET DURING FORECAST PERIOD
15.4.3
JAPAN
15.4.3.1
RISING NUMBER OF COLLABORATIONS IN NGS TO DRIVE MARKET
15.4.4
INDIA
15.4.4.1
GOVERNMENT AND PRIVATE INITIATIVES FOR GENOMICS PROJECTS TO PROPEL MARKET
15.4.5
AUSTRALIA
15.4.5.1
INCREASED GENETIC RESEARCH IN AUSTRALIA TO SUPPORT MARKET GROWTH
15.4.6
SOUTH KOREA
15.4.6.1
DEMAND FOR ADVANCED SEQUENCING TECHNOLOGIES TO SUPPORT MARKET GROWTH IN SOUTH KOREA
15.4.7
REST OF ASIA PACIFIC
15.5
LATIN AMERICA
15.5.1
LATIN AMERICA: MACROECONOMIC OUTLOOK
15.5.2
BRAZIL
15.5.2.1
INCREASED GOVERNMENT INVESTMENTS IN GENOMICS ADVANCEMENTS TO DRIVE MARKET
15.5.3
MEXICO
15.5.3.1
RISING DEMAND FOR CHRONIC DISEASE TREATMENT TO SUPPORT MARKET GROWTH IN MEXICO
15.5.4
REST OF LATIN AMERICA
15.6
MIDDLE EAST
15.6.1
MIDDLE EAST: MACROECONOMIC OUTLOOK
15.6.2
GCC COUNTRIES
15.6.2.1
SAUDI ARABIA
15.6.2.1.1
GROWING HEALTHCARE EXPENDITURE IN SAUDI ARABIA TO BOOST MARKET GROWTH
15.6.2.2
UAE
15.6.2.2.1
COLLABORATIONS TO ADVANCE GENOME SEQUENCING AND MARKET GROWTH
15.6.2.3
REST OF GCC COUNTRIES
15.6.3
REST OF MIDDLE EAST
15.7
AFRICA
15.7.1
GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET
15.7.2
AFRICA: MACROECONOMIC OUTLOOK
16
COMPETITIVE LANDSCAPE
Discover key players' winning strategies and market positions in the NGS competitive landscape.
573
16.1
INTRODUCTION
16.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
16.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NGS MARKET
16.3
REVENUE ANALYSIS, 2019–2023
16.4
MARKET SHARE ANALYSIS, 2023
16.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
16.5.1
STARS
16.5.2
EMERGING LEADERS
16.5.3
PERVASIVE PLAYERS
16.5.4
PARTICIPANTS
16.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2023
16.5.5.1
COMPANY FOOTPRINT
16.5.5.2
REGION FOOTPRINT
16.5.5.3
OFFERING FOOTPRINT
16.5.5.4
APPLICATION FOOTPRINT
16.5.5.5
TECHNOLOGY FOOTPRINT
16.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
16.6.1
PROGRESSIVE COMPANIES
16.6.2
RESPONSIVE COMPANIES
16.6.3
DYNAMIC COMPANIES
16.6.4
STARTING BLOCKS
16.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
16.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
16.6.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
16.7
VALUATION & FINANCIAL METRICS
16.7.1
FINANCIAL METRICS
16.7.2
COMPANY VALUATION
16.8
BRAND/PRODUCT COMPARISON
16.9
COMPETITIVE SCENARIO
16.9.1
DEALS
16.9.2
EXPANSIONS
17
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
593
17.1
KEY PLAYERS
17.1.1
ILLUMINA, INC.
17.1.1.1
BUSINESS OVERVIEW
17.1.1.2
PRODUCTS/SERVICES OFFERED
17.1.1.3
RECENT DEVELOPMENTS
17.1.1.3.1
PRODUCT LAUNCHES
17.1.1.3.2
DEALS
17.1.1.3.3
EXPANSIONS
17.1.1.4
MNM VIEW
17.1.1.4.1
KEY STRENGTHS
17.1.1.4.2
STRATEGIC CHOICES
17.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
17.1.2
THERMO FISHER SCIENTIFIC INC.
17.1.3
AGILENT TECHNOLOGIES, INC.
17.1.4
F. HOFFMANN-LA ROCHE LTD.
17.1.5
DANAHER CORPORATION
17.1.6
QIAGEN
17.1.7
REVVITY
17.1.8
EUROFINS SCIENTIFIC
17.1.9
PACBIO
17.1.10
OXFORD NANOPORE TECHNOLOGIES PLC.
17.1.11
TAKARA BIO INC.
17.1.12
BGI GROUP
17.1.13
BD
17.1.14
10X GENOMICS
17.1.15
PROMEGA CORPORATION
17.1.16
LGC LIMITED
17.1.17
WUXI BIOLOGICS
17.1.18
TECAN TRADING AG
17.1.19
TWIST BIOSCIENCES
17.1.20
AZENTA US, INC.
17.2
OTHER PLAYERS
17.2.1
MGI TECH CO. LTD.
17.2.2
NOVOGENE CO., LTD.
17.2.3
NEW ENGLAND BIOLABS
17.2.4
GENSCRIPT
17.2.5
PSOMAGEN
17.2.6
ZYMO RESEARCH CORPORATION
17.2.7
HAMILTON COMPANY
17.2.8
NEOGENOMICS LABORATORIES
17.2.9
FULGENT GENETICS
17.2.10
SD BIOSENSOR, INC.
18
APPENDIX
704
18.1
DISCUSSION GUIDE
18.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3
CUSTOMIZATION OPTIONS
18.4
RELATED REPORTS
18.5
AUTHOR DETAILS
LIST OF TABLES
TABLE 1
IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 2
NGS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
TABLE 3
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7
US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION
TABLE 8
US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 9
AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2022–2024 (USD)
TABLE 10
AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2022–2024 (USD)
TABLE 11
AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2024 (USD)
TABLE 12
AVERAGE SELLING PRICE OF INSTRUMENTS, BY REGION, 2024 (USD)
TABLE 13
INNOVATIONS AND PATENT REGISTRATIONS, 2020–2024
TABLE 14
NGS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 15
NGS MARKET: LIST OF KEY CONFERENCES AND EVENTS
TABLE 16
NGS MARKET: IMPACT OF PORTER’S FIVE FORCES
TABLE 17
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)
TABLE 18
KEY BUYING CRITERIA, BY END USER
TABLE 19
IMPORT DATA FOR HS CODE 3822 (VALUE), BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 20
IMPORT DATA FOR HS CODE 3822 (VOLUME), BY COUNTRY, 2019–2023 (TONS)
TABLE 21
EXPORT DATA FOR HS CODE 3822 (VALUE), BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 22
EXPORT DATA FOR HS CODE 3822 (VOLUME), BY COUNTRY, 2019–2023 (TONS)
TABLE 23
NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 24
NGS PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 25
NORTH AMERICA: NGS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 26
EUROPE: NGS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 27
ASIA PACIFIC: NGS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 28
LATIN AMERICA: NGS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 29
MIDDLE EAST: NGS PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 30
GCC COUNTRIES: NGS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31
NGS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 32
NORTH AMERICA: NGS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 33
EUROPE: NGS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 34
ASIA PACIFIC: NGS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 35
LATIN AMERICA: NGS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 36
MIDDLE EAST: NGS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 37
GCC COUNTRIES: NGS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38
NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 39
NGS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 40
NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 41
EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42
ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 43
LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 44
MIDDLE EAST: NGS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 45
GCC COUNTRIES: NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 46
NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 47
LIBRARY PREPARATION KITS & REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 48
NORTH AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 49
EUROPE: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 50
ASIA PACIFIC: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 51
LATIN AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 52
MIDDLE EAST: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 53
GCC COUNTRIES: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 54
SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 55
NORTH AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 56
EUROPE: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 57
ASIA PACIFIC: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 58
LATIN AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 59
MIDDLE EAST: SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 60
GCC COUNTRIES: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 61
OTHER NGS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 62
NORTH AMERICA: OTHER NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 63
EUROPE: OTHER NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 64
ASIA PACIFIC: OTHER NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 65
LATIN AMERICA: OTHER NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66
MIDDLE EAST: OTHER NGS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 67
GCC COUNTRIES: OTHER NGS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68
NGS PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 69
NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 70
EUROPE: NGS PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 71
ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 72
LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 73
MIDDLE EAST: NGS PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 74
GCC COUNTRIES: NGS PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75
NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 76
SEQUENCING PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 77
NORTH AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78
EUROPE: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 79
ASIA PACIFIC: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 80
LATIN AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 81
MIDDLE EAST: SEQUENCING PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 82
GCC COUNTRIES: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83
ILLUMINA SEQUENCING PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 84
ILLUMINA SEQUENCING PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 85
ILLUMINA SEQUENCING PLATFORMS MARKET, BY TYPE, 2022–2029 (UNITS)
TABLE 86
NOVASEQ SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 87
NEXTSEQ SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 88
MISEQ SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 89
MINISEQ SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 90
ISEQ SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 91
THERMO FISHER SCIENTIFIC SEQUENCING PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 92
THERMO FISHER SCIENTIFIC SEQUENCING PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 93
PACBIO SEQUENCING PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 94
OXFORD NANOPORE TECHNOLOGIES SEQUENCING PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 95
LIBRARY PREPARATION PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 96
NORTH AMERICA: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 97
EUROPE: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 98
ASIA PACIFIC: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 99
LATIN AMERICA: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 100
MIDDLE EAST: LIBRARY PREPARATION PLATFORMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 101
GCC COUNTRIES: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 102
NGS BIOINFORMATICS TOOLS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 103
NORTH AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 104
EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 105
ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 106
LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 107
MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 108
GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 109
NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 110
DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 111
NORTH AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 112
EUROPE: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 113
ASIA PACIFIC: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 114
LATIN AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115
MIDDLE EAST: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 116
GCC COUNTRIES: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117
DATA VISUALIZATION TOOLS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 118
NORTH AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 119
EUROPE: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 120
ASIA PACIFIC: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 121
LATIN AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 122
MIDDLE EAST: DATA VISUALIZATION TOOLS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 123
GCC COUNTRIES: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 124
OTHER BIOINFORMATICS TOOLS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 125
NORTH AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 126
EUROPE: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 127
ASIA PACIFIC: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 128
LATIN AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 129
MIDDLE EAST: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 130
GCC COUNTRIES: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 131
NGS TECHNOLOGIES, BY COMPANY
TABLE 132
NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 133
NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 134
NORTH AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 135
EUROPE: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 136
ASIA PACIFIC: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 137
LATIN AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 138
MIDDLE EAST: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 139
GCC COUNTRIES: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 140
NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
TABLE 141
NORTH AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 142
EUROPE: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 143
ASIA PACIFIC: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 144
LATIN AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145
MIDDLE EAST: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
TABLE 146
GCC COUNTRIES: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 147
NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
TABLE 148
NORTH AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 149
EUROPE: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 150
ASIA PACIFIC: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 151
LATIN AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 152
MIDDLE EAST: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
TABLE 153
GCC COUNTRIES: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 154
NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
TABLE 155
NORTH AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 156
EUROPE: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 157
ASIA PACIFIC: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 158
LATIN AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 159
MIDDLE EAST: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
TABLE 160
GCC COUNTRIES: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 161
NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 162
NORTH AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 163
EUROPE: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 164
ASIA PACIFIC: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 165
LATIN AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 166
MIDDLE EAST: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 167
GCC COUNTRIES: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 168
NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 169
NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)
TABLE 170
NORTH AMERICA: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 171
EUROPE: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 172
ASIA PACIFIC: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173
LATIN AMERICA: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 174
MIDDLE EAST: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)
TABLE 175
GCC COUNTRIES: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 176
NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)
TABLE 177
NORTH AMERICA: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 178
EUROPE: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 179
ASIA PACIFIC: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 180
LATIN AMERICA: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 181
MIDDLE EAST: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)
TABLE 182
GCC COUNTRIES: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 183
NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2022–2029 (USD MILLION)
TABLE 184
NORTH AMERICA: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 185
EUROPE: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 186
ASIA PACIFIC: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 187
LATIN AMERICA: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 188
MIDDLE EAST: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2022–2029 (USD MILLION)
TABLE 189
GCC COUNTRIES: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 190
NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 191
NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 192
NORTH AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 193
EUROPE: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 194
ASIA PACIFIC: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 195
LATIN AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 196
MIDDLE EAST: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 197
GCC COUNTRIES: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 198
NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 199
NORTH AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 200
EUROPE: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 201
ASIA PACIFIC: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 202
LATIN AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 203
MIDDLE EAST: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 204
GCC COUNTRIES: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 205
NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 206
NORTH AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 207
EUROPE: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 208
ASIA PACIFIC: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 209
LATIN AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 210
MIDDLE EAST: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 211
GCC COUNTRIES: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 212
NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 213
NORTH AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 214
EUROPE: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 215
ASIA PACIFIC: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 216
LATIN AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 217
MIDDLE EAST: NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 218
GCC COUNTRIES: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 219
NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 220
NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION)
TABLE 221
NORTH AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 222
EUROPE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 223
ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 224
LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 225
MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION)
TABLE 226
GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 227
NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 228
EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 229
NORTH AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 230
EUROPE: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 231
ASIA PACIFIC: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 232
LATIN AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 233
MIDDLE EAST: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 234
GCC COUNTRIES: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 235
RNA SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 236
NORTH AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 237
EUROPE: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 238
ASIA PACIFIC: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 239
LATIN AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 240
MIDDLE EAST: RNA SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 241
GCC COUNTRIES: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 242
DE NOVO SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 243
NORTH AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 244
EUROPE: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 245
ASIA PACIFIC: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 246
LATIN AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 247
MIDDLE EAST: DE NOVO SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 248
GCC COUNTRIES: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 249
CHIP SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 250
NORTH AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 251
EUROPE: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 252
ASIA PACIFIC: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 253
LATIN AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 254
MIDDLE EAST: CHIP SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 255
GCC COUNTRIES: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 256
WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 257
NORTH AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 258
EUROPE: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 259
ASIA PACIFIC: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 260
LATIN AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 261
MIDDLE EAST: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 262
GCC COUNTRIES: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 263
NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
TABLE 264
NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 265
EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 266
ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 267
LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 268
MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
TABLE 269
GCC COUNTRIES: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 270
OTHER SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 271
NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 272
EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 273
ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 274
LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 275
MIDDLE EAST: OTHER SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 276
GCC COUNTRIES: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 277
NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION)
TABLE 278
NORTH AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 279
EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 280
ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 281
LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 282
MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION)
TABLE 283
GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 284
NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 285
LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 286
NORTH AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 287
EUROPE: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 288
ASIA PACIFIC: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 289
LATIN AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 290
MIDDLE EAST: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 291
GCC COUNTRIES: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 292
SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 293
NORTH AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 294
EUROPE: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 295
ASIA PACIFIC: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 296
LATIN AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 297
MIDDLE EAST: SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 298
GCC COUNTRIES: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 299
QUALITY CONTROL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 300
NORTH AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 301
EUROPE: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 302
ASIA PACIFIC: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 303
LATIN AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 304
MIDDLE EAST: QUALITY CONTROL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 305
GCC COUNTRIES: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 306
NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY REGION, 2022–2029 (USD MILLION)
TABLE 307
NORTH AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 308
EUROPE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 309
ASIA PACIFIC: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 310
LATIN AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 311
MIDDLE EAST: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY REGION, 2022–2029 (USD MILLION)
TABLE 312
GCC COUNTRIES: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 313
NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 314
DATA ANALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 315
NORTH AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 316
EUROPE: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 317
ASIA PACIFIC: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 318
LATIN AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 319
MIDDLE EAST: DATA ANALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 320
GCC COUNTRIES: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 321
DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 322
NORTH AMERICA: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 323
EUROPE: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 324
ASIA PACIFIC: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 325
LATIN AMERICA: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 326
MIDDLE EAST: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 327
GCC COUNTRIES: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 328
DATA STORAGE & MANAGEMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 329
NORTH AMERICA: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 330
EUROPE: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 331
ASIA PACIFIC: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 332
LATIN AMERICA: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 333
MIDDLE EAST: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 334
GCC COUNTRIES: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 335
NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY REGION, 2022–2029 (USD MILLION)
TABLE 336
NORTH AMERICA: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 337
EUROPE: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 338
ASIA PACIFIC: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 339
LATIN AMERICA: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 340
MIDDLE EAST: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY REGION, 2022–2029 (USD MILLION)
TABLE 341
GCC COUNTRIES: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 342
NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 343
NGS SERVICES MARKET FOR SEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)
TABLE 344
NORTH AMERICA: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 345
EUROPE: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 346
ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 347
LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 348
MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)
TABLE 349
GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 350
NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)
TABLE 351
NORTH AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 352
EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 353
ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 354
LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 355
MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY REGION, 2022–2029 (USD MILLION)
TABLE 356
GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 357
NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2022–2029 (USD MILLION)
TABLE 358
NORTH AMERICA: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 359
EUROPE: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 360
ASIA PACIFIC: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 361
LATIN AMERICA: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 362
MIDDLE EAST: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2022–2029 (USD MILLION)
TABLE 363
GCC COUNTRIES: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 364
NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 365
NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 366
NORTH AMERICA: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 367
EUROPE: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 368
ASIA PACIFIC: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 369
LATIN AMERICA: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 370
MIDDLE EAST: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 371
GCC COUNTRIES: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 372
NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 373
NORTH AMERICA: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 374
EUROPE: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 375
ASIA PACIFIC: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 376
LATIN AMERICA: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 377
MIDDLE EAST: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 378
GCC COUNTRIES: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 379
NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 380
NORTH AMERICA: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 381
EUROPE: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 382
ASIA PACIFIC: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 383
LATIN AMERICA: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 384
MIDDLE EAST: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 385
GCC COUNTRIES: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 386
NGS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 387
NORTH AMERICA: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 388
EUROPE: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 389
ASIA PACIFIC: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 390
LATIN AMERICA: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 391
MIDDLE EAST: NGS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 392
GCC COUNTRIES: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 393
NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 394
NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 395
NORTH AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 396
EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 397
ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 398
LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 399
MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 400
GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 401
NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 402
FUNDING AND GRANTS FOR CANCER RESEARCH, BY TYPE (AS OF JANUARY 2023)
TABLE 403
NGS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 404
NORTH AMERICA: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 405
EUROPE: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 406
ASIA PACIFIC: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 407
LATIN AMERICA: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 408
MIDDLE EAST: NGS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 409
GCC COUNTRIES: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 410
NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 411
NORTH AMERICA: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 412
EUROPE: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 413
ASIA PACIFIC: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 414
LATIN AMERICA: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 415
MIDDLE EAST: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 416
GCC COUNTRIES: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 417
NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 418
NORTH AMERICA: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 419
EUROPE: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 420
ASIA PACIFIC: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 421
LATIN AMERICA: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 422
MIDDLE EAST: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 423
GCC COUNTRIES: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 424
NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 425
NORTH AMERICA: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 426
EUROPE: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 427
ASIA PACIFIC: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 428
LATIN AMERICA: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 429
MIDDLE EAST: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 430
GCC COUNTRIES: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 431
NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 432
NORTH AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 433
EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 434
ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 435
LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 436
MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 437
GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 438
NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 439
NGS MARKET FOR PHARMACOGENOMICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 440
NORTH AMERICA: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 441
EUROPE: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 442
ASIA PACIFIC: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 443
LATIN AMERICA: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 444
MIDDLE EAST: NGS MARKET FOR PHARMACOGENOMICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 445
GCC COUNTRIES: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 446
NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 447
NORTH AMERICA: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 448
EUROPE: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 449
ASIA PACIFIC: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 450
LATIN AMERICA: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 451
MIDDLE EAST: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 452
GCC COUNTRIES: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 453
NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 454
NORTH AMERICA: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 455
EUROPE: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 456
ASIA PACIFIC: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 457
LATIN AMERICA: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 458
MIDDLE EAST: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 459
GCC COUNTRIES: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 460
NGS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 461
NORTH AMERICA: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 462
EUROPE: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 463
ASIA PACIFIC: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 464
LATIN AMERICA: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 465
MIDDLE EAST: NGS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 466
GCC COUNTRIES: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 467
NGS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 468
NORTH AMERICA: KEY MACROINDICATORS
TABLE 469
NORTH AMERICA: NGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 470
NORTH AMERICA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 471
NORTH AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 472
NORTH AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 473
NORTH AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 474
NORTH AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 475
NORTH AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 476
NORTH AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 477
NORTH AMERICA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 478
NORTH AMERICA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 479
NORTH AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 480
NORTH AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 481
NORTH AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 482
NORTH AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 483
NORTH AMERICA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 484
NORTH AMERICA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 485
NORTH AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 486
NORTH AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 487
US: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 488
US: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 489
US: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 490
US: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 491
US: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 492
US: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 493
US: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 494
US: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 495
US: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 496
US: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 497
US: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 498
US: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 499
US: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 500
US: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 501
US: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 502
US: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 503
US: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 504
CANADA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 505
CANADA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 506
CANADA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 507
CANADA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 508
CANADA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 509
CANADA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 510
CANADA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 511
CANADA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 512
CANADA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 513
CANADA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 514
CANADA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 515
CANADA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 516
CANADA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 517
CANADA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 518
CANADA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 519
CANADA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 520
CANADA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 521
EUROPE: KEY MACROINDICATORS
TABLE 522
EUROPE: NGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 523
EUROPE: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 524
EUROPE: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 525
EUROPE: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 526
EUROPE: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 527
EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 528
EUROPE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 529
EUROPE: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 530
EUROPE: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 531
EUROPE: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 532
EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 533
EUROPE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 534
EUROPE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 535
EUROPE: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 536
EUROPE: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 537
EUROPE: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 538
EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 539
EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 540
GERMANY: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 541
GERMANY: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 542
GERMANY: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 543
GERMANY: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 544
GERMANY: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 545
GERMANY: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 546
GERMANY: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 547
GERMANY: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 548
GERMANY: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 549
GERMANY: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 550
GERMANY: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 551
GERMANY: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 552
GERMANY: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 553
GERMANY: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 554
GERMANY: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 555
GERMANY: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 556
GERMANY: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 557
UK: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 558
UK: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 559
UK: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 560
UK: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 561
UK: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 562
UK: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 563
UK: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 564
UK: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 565
UK: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 566
UK: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 567
UK: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 568
UK: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 569
UK: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 570
UK: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 571
UK: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 572
UK: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 573
UK: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 574
FRANCE: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 575
FRANCE: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 576
FRANCE: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 577
FRANCE: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 578
FRANCE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 579
FRANCE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 580
FRANCE: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 581
FRANCE: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 582
FRANCE: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 583
FRANCE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 584
FRANCE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 585
FRANCE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 586
FRANCE: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 587
FRANCE: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 588
FRANCE: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 589
FRANCE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 590
FRANCE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 591
ITALY: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 592
ITALY: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 593
ITALY: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 594
ITALY: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 595
ITALY: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 596
ITALY: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 597
ITALY: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 598
ITALY: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 599
ITALY: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 600
ITALY: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 601
ITALY: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 602
ITALY: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 603
ITALY: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 604
ITALY: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 605
ITALY: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 606
ITALY: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 607
ITALY: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 608
SPAIN: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 609
SPAIN: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 610
SPAIN: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 611
SPAIN: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 612
SPAIN: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 613
SPAIN: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 614
SPAIN: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 615
SPAIN: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 616
SPAIN: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 617
SPAIN: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 618
SPAIN: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 619
SPAIN: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 620
SPAIN: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 621
SPAIN: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 622
SPAIN: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 623
SPAIN: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 624
SPAIN: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 625
NETHERLANDS: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 626
NETHERLANDS: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 627
NETHERLANDS: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 628
NETHERLANDS: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 629
NETHERLANDS: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 630
NETHERLANDS: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 631
NETHERLANDS: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 632
NETHERLANDS: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 633
NETHERLANDS: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 634
NETHERLANDS: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 635
NETHERLANDS: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 636
NETHERLANDS: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 637
NETHERLANDS: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 638
NETHERLANDS: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 639
NETHERLANDS: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 640
NETHERLANDS: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 641
NETHERLANDS: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 642
REST OF EUROPE: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 643
REST OF EUROPE: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 644
REST OF EUROPE: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 645
REST OF EUROPE: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 646
REST OF EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 647
REST OF EUROPE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 648
REST OF EUROPE: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 649
REST OF EUROPE: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 650
REST OF EUROPE: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 651
REST OF EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 652
REST OF EUROPE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 653
REST OF EUROPE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 654
REST OF EUROPE: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 655
REST OF EUROPE: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 656
REST OF EUROPE: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 657
REST OF EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 658
REST OF EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 659
ASIA PACIFIC: KEY MACROINDICATORS
TABLE 660
ASIA PACIFIC: NGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 661
ASIA PACIFIC: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 662
ASIA PACIFIC: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 663
ASIA PACIFIC: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 664
ASIA PACIFIC: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 665
ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 666
ASIA PACIFIC: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 667
ASIA PACIFIC: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 668
ASIA PACIFIC: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 669
ASIA PACIFIC: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 670
ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 671
ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 672
ASIA PACIFIC: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 673
ASIA PACIFIC: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 674
ASIA PACIFIC: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 675
ASIA PACIFIC: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 676
ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 677
ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 678
CHINA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 679
CHINA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 680
CHINA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 681
CHINA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 682
CHINA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 683
CHINA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 684
CHINA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 685
CHINA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 686
CHINA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 687
CHINA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 688
CHINA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 689
CHINA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 690
CHINA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 691
CHINA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 692
CHINA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 693
CHINA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 694
CHINA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 695
JAPAN: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 696
JAPAN: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 697
JAPAN: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 698
JAPAN: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 699
JAPAN: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 700
JAPAN: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 701
JAPAN: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 702
JAPAN: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 703
JAPAN: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 704
JAPAN: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 705
JAPAN: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 706
JAPAN: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 707
JAPAN: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 708
JAPAN: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 709
JAPAN: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 710
JAPAN: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 711
JAPAN: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 712
INDIA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 713
INDIA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 714
INDIA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 715
INDIA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 716
INDIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 717
INDIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 718
INDIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 719
INDIA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 720
INDIA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 721
INDIA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 722
INDIA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 723
INDIA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 724
INDIA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 725
INDIA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 726
INDIA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 727
INDIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 728
INDIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 729
AUSTRALIA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 730
AUSTRALIA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 731
AUSTRALIA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 732
AUSTRALIA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 733
AUSTRALIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 734
AUSTRALIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 735
AUSTRALIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 736
AUSTRALIA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 737
AUSTRALIA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 738
AUSTRALIA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 739
AUSTRALIA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 740
AUSTRALIA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 741
AUSTRALIA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 742
AUSTRALIA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 743
AUSTRALIA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 744
AUSTRALIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 745
AUSTRALIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 746
SOUTH KOREA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 747
SOUTH KOREA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 748
SOUTH KOREA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 749
SOUTH KOREA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 750
SOUTH KOREA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 751
SOUTH KOREA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 752
SOUTH KOREA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 753
SOUTH KOREA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 754
SOUTH KOREA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 755
SOUTH KOREA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 756
SOUTH KOREA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 757
SOUTH KOREA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 758
SOUTH KOREA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 759
SOUTH KOREA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 760
SOUTH KOREA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 761
SOUTH KOREA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 762
SOUTH KOREA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 763
REST OF ASIA PACIFIC: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 764
REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 765
REST OF ASIA PACIFIC: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 766
REST OF ASIA PACIFIC: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 767
REST OF ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 768
REST OF ASIA PACIFIC: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 769
REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 770
REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 771
REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 772
REST OF ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 773
REST OF ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 774
REST OF ASIA PACIFIC: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 775
REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 776
REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 777
REST OF ASIA PACIFIC: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 778
REST OF ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 779
REST OF ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 780
LATIN AMERICA: KEY MACROINDICATORS
TABLE 781
LATIN AMERICA: NGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 782
LATIN AMERICA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 783
LATIN AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 784
LATIN AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 785
LATIN AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 786
LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 787
LATIN AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 788
LATIN AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 789
LATIN AMERICA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 790
LATIN AMERICA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 791
LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 792
LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 793
LATIN AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 794
LATIN AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 795
LATIN AMERICA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 796
LATIN AMERICA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 797
LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 798
LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 799
BRAZIL: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 800
BRAZIL: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 801
BRAZIL: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 802
BRAZIL: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 803
BRAZIL: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 804
BRAZIL: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 805
BRAZIL: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 806
BRAZIL: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 807
BRAZIL: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 808
BRAZIL: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 809
BRAZIL: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 810
BRAZIL: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 811
BRAZIL: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 812
BRAZIL: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 813
BRAZIL: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 814
BRAZIL: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 815
BRAZIL: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 816
MEXICO: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 817
MEXICO: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 818
MEXICO: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 819
MEXICO: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 820
MEXICO: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 821
MEXICO: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 822
MEXICO: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 823
MEXICO: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 824
MEXICO: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 825
MEXICO: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 826
MEXICO: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 827
MEXICO: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 828
MEXICO: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 829
MEXICO: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 830
MEXICO: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 831
MEXICO: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 832
MEXICO: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 833
REST OF LATIN AMERICA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 834
REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 835
REST OF LATIN AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 836
REST OF LATIN AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 837
REST OF LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 838
REST OF LATIN AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 839
REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 840
REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 841
REST OF LATIN AMERICA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 842
REST OF LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 843
REST OF LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 844
REST OF LATIN AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 845
REST OF LATIN AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 846
REST OF LATIN AMERICA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 847
REST OF LATIN AMERICA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 848
REST OF LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 849
REST OF LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 850
MIDDLE EAST: KEY MACROINDICATORS
TABLE 851
MIDDLE EAST: NGS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 852
MIDDLE EAST: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 853
MIDDLE EAST: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 854
MIDDLE EAST: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 855
MIDDLE EAST: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 856
MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 857
MIDDLE EAST: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 858
MIDDLE EAST: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 859
MIDDLE EAST: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 860
MIDDLE EAST: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 861
MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 862
MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 863
MIDDLE EAST: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 864
MIDDLE EAST: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 865
MIDDLE EAST: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 866
MIDDLE EAST: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 867
MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 868
MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 869
GCC COUNTRIES: NGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 870
GCC COUNTRIES: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 871
GCC COUNTRIES: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 872
GCC COUNTRIES: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 873
GCC COUNTRIES: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 874
GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 875
GCC COUNTRIES: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 876
GCC COUNTRIES: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 877
GCC COUNTRIES: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 878
GCC COUNTRIES: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 879
GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 880
GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 881
GCC COUNTRIES: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 882
GCC COUNTRIES: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 883
GCC COUNTRIES: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 884
GCC COUNTRIES: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 885
GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 886
GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 887
SAUDI ARABIA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 888
SAUDI ARABIA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 889
SAUDI ARABIA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 890
SAUDI ARABIA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 891
SAUDI ARABIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 892
SAUDI ARABIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 893
SAUDI ARABIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 894
SAUDI ARABIA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 895
SAUDI ARABIA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 896
SAUDI ARABIA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 897
SAUDI ARABIA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 898
SAUDI ARABIA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 899
SAUDI ARABIA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 900
SAUDI ARABIA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 901
SAUDI ARABIA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 902
SAUDI ARABIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 903
SAUDI ARABIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 904
UAE: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 905
UAE: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 906
UAE: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 907
UAE: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 908
UAE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 909
UAE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 910
UAE: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 911
UAE: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 912
UAE: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 913
UAE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 914
UAE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 915
UAE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 916
UAE: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 917
UAE: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 918
UAE: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 919
UAE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 920
UAE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 921
REST OF GCC COUNTRIES: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 922
REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 923
REST OF GCC COUNTRIES: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 924
REST OF GCC COUNTRIES: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 925
REST OF GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 926
REST OF GCC COUNTRIES: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 927
REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 928
REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 929
REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 930
REST OF GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 931
REST OF GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 932
REST OF GCC COUNTRIES: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 933
REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 934
REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 935
REST OF GCC COUNTRIES: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 936
REST OF GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 937
REST OF GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 938
REST OF MIDDLE EAST: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 939
REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 940
REST OF MIDDLE EAST: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 941
REST OF MIDDLE EAST: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 942
REST OF MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 943
REST OF MIDDLE EAST: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 944
REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 945
REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 946
REST OF MIDDLE EAST: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 947
REST OF MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 948
REST OF MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 949
REST OF MIDDLE EAST: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 950
REST OF MIDDLE EAST: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 951
REST OF MIDDLE EAST: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 952
REST OF MIDDLE EAST: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 953
REST OF MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 954
REST OF MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 955
MACROECONOMIC OUTLOOK FOR NGS MARKET IN AFRICA
TABLE 956
AFRICA: NGS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 957
AFRICA: NGS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 958
AFRICA: NGS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 959
AFRICA: NGS PLATFORMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 960
AFRICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 961
AFRICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 962
AFRICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 963
AFRICA: NGS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 964
AFRICA: NGS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 965
AFRICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 966
AFRICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 967
AFRICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 968
AFRICA: NGS SERVICES MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
TABLE 969
AFRICA: NGS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 970
AFRICA: NGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 971
AFRICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 972
AFRICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 973
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN NGS MARKET
TABLE 974
NGS MARKET: DEGREE OF COMPETITION
TABLE 975
NGS MARKET: REGION FOOTPRINT
TABLE 976
NGS MARKET: OFFERING FOOTPRINT
TABLE 977
NGS MARKET: APPLICATION FOOTPRINT
TABLE 978
NGS PLATFORMS MARKET: TECHNOLOGY FOOTPRINT
TABLE 979
NGS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 980
NGS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
TABLE 981
NGS MARKET: DEALS, JANUARY 2021– DECEMBER 2024
TABLE 982
NGS MARKET: EXPANSIONS, JANUARY 2021–DECEMBER 2024
TABLE 983
ILLUMINA: COMPANY OVERVIEW
TABLE 984
ILLUMINA: PRODUCTS/SERVICES OFFERED
TABLE 985
ILLUMINA: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 986
ILLUMINA: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 987
ILLUMINA: EXPANSIONS, JANUARY 2021–DECEMBER 2024
TABLE 988
THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW
TABLE 989
THERMO FISHER SCIENTIFIC: PRODUCTS/SERVICES OFFERED
TABLE 990
THERMO FISHER SCIENTIFIC: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2021–DECEMBER 2024
TABLE 991
THERMO FISHER SCIENTIFIC: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 992
THERMO FISHER SCIENTIFIC: EXPANSIONS, JANUARY 2021–DECEMBER 2024
TABLE 993
AGILENT TECHNOLOGIES: COMPANY OVERVIEW
TABLE 994
AGILENT TECHNOLOGIES: PRODUCTS/SERVICES OFFERED
TABLE 995
AGILENT TECHNOLOGIES: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 996
AGILENT TECHNOLOGIES: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 997
AGILENT TECHNOLOGIES: EXPANSIONS, JANUARY 2021–DECEMBER 2024
TABLE 998
F. HOFFMANN-LA ROCHE: COMPANY OVERVIEW
TABLE 999
F. HOFFMANN-LA ROCHE: PRODUCTS/SERVICES OFFERED
TABLE 1000
F. HOFFMANN-LA ROCHE: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 1001
F. HOFFMANN-LA ROCHE: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 1002
DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 1003
DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 1004
DANAHER CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024
TABLE 1005
DANAHER CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 1006
DANAHER CORPORATION: EXPANSIONS, JANUARY 2021–DECEMBER 2024
TABLE 1007
QIAGEN: COMPANY OVERVIEW
TABLE 1008
QIAGEN: PRODUCTS/SERVICES OFFERED
TABLE 1009
QIAGEN: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 1010
QIAGEN: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 1011
QIAGEN: EXPANSIONS, JANUARY 2021–DECEMBER 2024
TABLE 1012
REVVITY: COMPANY OVERVIEW
TABLE 1013
REVVITY: PRODUCTS/SERVICES OFFERED
TABLE 1014
REVVITY: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 1015
REVVITY: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 1016
REVVITY: EXPANSIONS, JANUARY 2021–DECEMBER 2024
TABLE 1017
EUROFINS SCIENTIFIC: COMPANY OVERVIEW
TABLE 1018
EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
TABLE 1019
EUROFINS SCIENTIFIC: SERVICE LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 1020
EUROFINS SCIENTIFIC: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 1021
PACBIO: COMPANY OVERVIEW
TABLE 1022
PACBIO: PRODUCTS/SERVICES OFFERED
TABLE 1023
PACBIO: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 1024
PACBIO: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 1025
PACBIO: EXPANSIONS, JANUARY 2021–DECEMBER 2024
TABLE 1026
PACBIO: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024
TABLE 1027
OXFORD NANOPORE TECHNOLOGIES: COMPANY OVERVIEW
TABLE 1028
OXFORD NANOPORE TECHNOLOGIES: PRODUCTS/SERVICES OFFERED
TABLE 1029
OXFORD NANOPORE TECHNOLOGIES: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 1030
OXFORD NANOPORE TECHNOLOGIES: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 1031
TAKARA BIO: COMPANY OVERVIEW
TABLE 1032
TAKARA BIO: PRODUCTS/SERVICES OFFERED
TABLE 1033
TAKARA BIO: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 1034
TAKARA BIO: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 1035
BGI GROUP: COMPANY OVERVIEW
TABLE 1036
BGI GROUP: PRODUCTS/SERVICES OFFERED
TABLE 1037
BGI GROUP: PRODUCT & SERVICE LAUNCHES AND APPROVALS, JANUARY 2021–DECEMBER 2024
TABLE 1038
BGI GROUP: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 1039
BGI GROUP: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024
TABLE 1040
BD: COMPANY OVERVIEW
TABLE 1041
BD: PRODUCTS/SERVICES OFFERED
TABLE 1042
BD: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 1043
BD: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 1044
10X GENOMICS: COMPANY OVERVIEW
TABLE 1045
10X GENOMICS: PRODUCTS/SERVICES OFFERED
TABLE 1046
10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 1047
PROMEGA CORPORATION: COMPANY OVERVIEW
TABLE 1048
PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 1049
PROMEGA CORPORATION: EXPANSIONS, JANUARY 2021–DECEMBER 2024
TABLE 1050
LGC LIMITED: COMPANY OVERVIEW
TABLE 1051
LGC LIMITED: PRODUCTS/SERVICES OFFERED
TABLE 1052
LGC LIMITED: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 1053
WUXI BIOLOGICS: COMPANY OVERVIEW
TABLE 1054
WUXI BIOLOGICS: PRODUCTS/SERVICES OFFERED
TABLE 1055
TECAN TRADING AG: COMPANY OVERVIEW
TABLE 1056
TECAN TRADING AG: PRODUCTS/SERVICES OFFERED
TABLE 1057
TECAN TRADING AG: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 1058
TWIST BIOSCIENCE: COMPANY OVERVIEW
TABLE 1059
TWIST BIOSCIENCE: PRODUCTS/SERVICES OFFERED
TABLE 1060
TWIST BIOSCIENCES: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 1061
TWIST BIOSCIENCE: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 1062
AZENTA US: COMPANY OVERVIEW
TABLE 1063
AZENTA US: PRODUCTS & SERVICES OFFERED
TABLE 1064
AZENTA US: DEALS, JANUARY 2021–DECEMBER 2024
LIST OF FIGURES
FIGURE 1
RESEARCH DESIGN
FIGURE 2
NGS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
FIGURE 3
NGS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
FIGURE 4
MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
FIGURE 5
REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF ILLUMINA, INC. (2023)
FIGURE 6
MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 7
MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 8
NGS MARKET: CAGR PROJECTIONS
FIGURE 9
DATA TRIANGULATION METHODOLOGY
FIGURE 10
NGS MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
FIGURE 11
NGS PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 12
NGS PLATFORMS MARKET, BY TECHNOLOGY 2024 VS. 2029 (USD MILLION)
FIGURE 13
NGS SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 14
NGS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 15
NGS SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 16
NGS MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 17
TECHNOLOGICAL ADVANCEMENTS IN GENOME SEQUENCING TO DRIVE MARKET GROWTH
FIGURE 18
CONSUMABLES ACCOUNTED FOR LARGEST SHARE IN ASIA PACIFIC IN 2023
FIGURE 19
CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 20
ACADEMIC & RESEARCH INSTITUTES TO DOMINATE PRODUCTS MARKET DURING FORECAST PERIOD
FIGURE 21
NGS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 22
REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS
FIGURE 23
NGS MARKET: VALUE CHAIN ANALYSIS
FIGURE 24
VALUE CHAIN ANALYSIS: SEQUENCING & ANALYSIS ADD MAXIMUM VALUE
FIGURE 25
AVERAGE SELLING PRICE OF INSTRUMENTS, BY KEY PLAYER, 2024 (USD)
FIGURE 26
AVERAGE SELLING PRICE OF CONSUMABLES, BY KEY PLAYER, 2024 (USD)
FIGURE 27
AVERAGE SELLING PRICE OF SERVICES, 2024 (USD)
FIGURE 28
AVERAGE SELLING PRICE OF INSTRUMENTS, BY REGION, 2024 (USD)
FIGURE 29
PATENT ANALYSIS FOR NGS MARKET, 2014–2024
FIGURE 30
NGS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 31
NGS MARKET: ECOSYSTEM ANALYSIS
FIGURE 32
NGS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 33
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
FIGURE 34
KEY BUYING CRITERIA, BY END USER
FIGURE 35
RESEARCH FUNDING BY VARIOUS INSTITUTES/CENTERS, 2020–2024 (USD MILLION)
FIGURE 36
IMPACT OF AI/GEN AI ON NEXT-GENERATION SEQUENCING MARKET
FIGURE 37
NORTH AMERICA: NGS MARKET SNAPSHOT
FIGURE 38
ASIA PACIFIC: NGS MARKET SNAPSHOT
FIGURE 39
REVENUE ANALYSIS OF KEY PLAYERS IN NGS MARKET, 2019–2023 (USD MILLION)
FIGURE 40
NGS MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
FIGURE 41
NGS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 42
NGS MARKET: COMPANY FOOTPRINT
FIGURE 43
NGS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 44
EV/EBITDA OF KEY VENDORS
FIGURE 45
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 46
NGS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 47
ILLUMINA: COMPANY SNAPSHOT (2023)
FIGURE 48
THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2023)
FIGURE 49
AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2023)
FIGURE 50
F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2023)
FIGURE 51
DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 52
QIAGEN: COMPANY SNAPSHOT (2023)
FIGURE 53
REVVITY: COMPANY SNAPSHOT (2023)
FIGURE 54
EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
FIGURE 55
PACBIO: COMPANY SNAPSHOT (2023)
FIGURE 56
OXFORD NANOPORE TECHNOLOGIES: COMPANY SNAPSHOT (2023)
FIGURE 57
TAKARA BIO: COMPANY SNAPSHOT (2023)
FIGURE 58
BD: COMPANY SNAPSHOT (2023)
FIGURE 59
10X GENOMICS: COMPANY SNAPSHOT (2023)
FIGURE 60
LGC LIMITED: COMPANY SNAPSHOT (2023)
FIGURE 61
WUXI BIOLOGICS: COMPANY SNAPSHOT (2023)
FIGURE 62
TECAN TRADING AG: COMPANY SNAPSHOT (2023)
FIGURE 63
TWIST BIOSCIENCE: COMPANY SNAPSHOT (2023)
FIGURE 64
AZENTA US: COMPANY SNAPSHOT (2023)
Methodology
This study on the next-generation sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the next-generation sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.
Secondary Research
The secondary sources referred to for this research study include publications from government sources. These include the Centers for Disease Control and Prevention (CDC), the US Food and Drug Administration (FDA), the World Health Organization (WHO), the American Cancer Society (ACS), the National Center for Biotechnology Information (NCBI), the National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI), International Agency for Research on Cancer (IARC), National Institute for Infectious Diseases (IRCCS), Association for Clinical Genomic Science (ACGS), American Society of Human Genetics (ASHG), European Society of Human Genetics (ESHG), Asia Pacific Society of Human Genetics (APSHG), Nature Reviews Genetics, Nature Methods, Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Genome Research, National Cancer Institute (NCI), European Medicines Agency (EMA), Population Health Research Institute (PHRI), PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global next-generation sequencing market, which was validated through primary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global next-generation sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing NGS; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries, CROs, and other end users. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the next-generation sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
NGS refers to non-Sanger-based, high-throughput DNA sequencing technologies. DNA strands can be sequenced simultaneously, yielding substantially more throughput and minimizing the need for fragment-cloning methods often used in the Sanger sequencing of genomes. NGS is fundamentally based on sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, and nanopore sequencing.
Stakeholders
- NGS instrument manufacturers, vendors, and distributors
- NGS service providers
- NGS bioinformatics/data analysis companies
- Research laboratories and academic institutes
- Venture capitalists and other government funding organizations
- Research and consulting firms
- Healthcare institutions (hospitals and diagnostic clinics)
- Pharmaceutical and biotechnology companies
- Academic and government research institutes
- Life science companies
Report Objectives
- To define, describe, and forecast the next-generation sequencing market based on offerings, product type, platform technology, product workflow, product end user, service type, service workflow, service end user, application, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall next-generation sequencing market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global next-generation sequencing market and comprehensively analyze their platforms, reagents, kits, consumables, and services portfolios, market positions, and core competencies
- To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the next-generation sequencing market
- To benchmark players within the next-generation sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy
Key Questions Addressed by the Report
What revenue strategies are market leaders using to dominate the Next-Generation Sequencing Industry by 2029?
Market leaders like Illumina and Roche are using bundled contracts that include reagents, software, and maintenance, turning instrument sales into long-term revenue streams. Thermo Fisher is expanding its reach through complete sequencing solutions using the Ion Torrent Genexus Dx platform. Companies are also forming partnerships, such as Illumina's collaboration with NVIDIA, to offer GPU-accelerated cloud analysis. By 2029, compact sequencers from Oxford Nanopore and Genapsys are expected to expand real-time and remote lab applications.
Which overlooked markets are emerging as high-ROI zones in the Next-Generation Sequencing Industry?
Latin America, Southeast Asia, and Africa are emerging as high-return markets. In Mexico, the OriGen project is sequencing over 10,000 genomes, making it attractive for local NGS investments. In March 2025, Illumina renewed its partnership with Africa CDC to equip national labs with NGS tools. In Southeast Asia, Gene Solutions partnered with Element Biosciences in April 2025 to bring cost-effective NIPT and oncology assays to Singapore and Vietnam.
How are fast-track approvals in North America driving early revenue for Next-Generation Sequencing players?
FDA fast-track programs have helped companies reduce approval times and generate revenue earlier. In October 2024, Thermo Fisher received FDA approval for the Oncomine Dx Target Test, quickly unlocking cartridge orders and contracts. Illumina’s TruSight Oncology panel was approved in August 2024 and also secured early Medicare coverage, helping the company capture initial sales sooner than expected.
What funding signal the next big shift in the Next-Generation Sequencing Market?
Recent investments are focusing on software, consumables, and hardware innovation. In May 2025, SeqOne Genomics raised USD 23.2 million to expand its AI-driven platform. In January 2025, Senseera secured USD 7.1 million for its liquid biopsy technology. In July 2024, Element Biosciences raised USD 277 million to support its high-throughput AVITI sequencer. These investments indicate a shift toward software development, non-invasive diagnostics, and next-generation instruments.
What key innovation gaps offer untapped revenue potential in the Next-Generation Sequencing Market?
The market still lacks standardized, cloud-based bioinformatics tools, which could generate strong subscription-based revenue. Fully automated, microfluidic sample-to-answer platforms are another gap that could drive premium consumables and service contracts. Long-read systems that lower sequencing costs are also in demand. Companies like Ultima Genomics and Standard Bio are working to address these areas.
How are go-to-market models evolving to win in Asia Pacific?
In the Asia Pacific region, companies are forming local partnerships to leverage regulatory and bioinformatics expertise. For instance, in March 2023, Qiagen collaborated with SOPHiA Genetics to combine reagents with analytics in India and Southeast Asia. Illumina introduced the NovaSeqX platform in Thailand in October 2022, reducing per-sample costs and encouraging adoption in cost-sensitive markets.
How are supply chain shifts affecting profitability in the Next-Generation Sequencing Market?
Regulatory actions and localization efforts are changing how companies manage their supply chains. In March 2025, China banned the import of Illumina sequencers, forcing the company to reduce costs by 100 million dollars and revise its earnings guidance. At the same time, companies like Thermo Fisher have localized production, with its May 2023 facility in Singapore reducing logistics costs and improving margins on consumables.
Which technologies are accelerating market access and scale in the Next-Generation Sequencing Market?
Sample-to-answer platforms are speeding up adoption by simplifying workflows. Thermo Fisher’s Genexus System completes sequencing and analysis in under 24 hours, helping smaller labs implement NGS. In May 2024, Illumina launched an AI-driven variant calling tool that reduced analysis time to two hours. BGI’s new hub in Singapore now serves over 5,000 institutes with scalable cloud computing resources.
What government programs are fueling growth in the Next-Generation Sequencing Market across Regions?
Several national programs are creating demand for NGS technologies. In India, the Genome India Project launched in January 2020 is sequencing 10,000 genomes and building lab infrastructure. China’s 2023 Clinical Sequencing Pilot Program allows early commercialization of various assays. The European Union’s GenAI4EU program, launched in May 2024 under Horizon Europe, is investing 818 million dollars in AI-driven bioinformatics through 2027.
How are competitors aligning products with buyer needs in Asia Pacific?
In Asia Pacific, companies are adapting to local needs by developing region-specific products. GeneLife, a Japanese company, partnered with Illumina to create direct-to-consumer kits and a wellness app focused on Asian genetic variants. In October 2022, Pacific Biosciences introduced the Revio and Onso platforms across the region, giving labs a range of affordable and scalable options tailored to varying budgets and throughput demands.
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
Fact checked
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Next-generation Sequencing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationGrowth opportunities and latent adjacency in Next-generation Sequencing Market
Jackson
May, 2022
Which company and region dominates the Next generation Sequencing Market ?.
James
May, 2022
What is the most popular next-generation sequencing platform today in Next generation Sequencing Market ?.